BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...

A team led by researchers from Case Western Reserve University and Cleveland Clinic have received a four-year, $2.95 million grant from the National Institutes of Health to explore how imaging can be ...

Most deaths from melanoma—the most lethal form of skin cancer—occur in patients who were initially diagnosed with early-stage melanoma and then later experienced a recurrence that is typically not ...